Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3045% below fair value
$35.57+0.65 (+1.86%)
Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%
Phibro Animal Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Phibro Animal Health's revenue for the twelve months ending Jun 30, 2026 was $1.52B, up 17.1% year over year. For fiscal 2026 it was $1.52B, up 17.1% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $1.52B in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.52B | +17.1% |
| FY2025 | Jun 30, 2025 | $1.30B | +27.4% |
| FY2024 | Jun 30, 2024 | $1.02B | +4.1% |
| FY2023 | Jun 30, 2023 | $977.89M | +3.8% |
| FY2022 | Jun 30, 2022 | $942.26M | +13.1% |
| FY2021 | Jun 30, 2021 | $833.35M | +4.1% |
| FY2020 | Jun 30, 2020 | $800.35M | -3.3% |
| FY2019 | Jun 30, 2019 | $828.00M | +1.0% |
| FY2018 | Jun 30, 2018 | $819.98M | +7.3% |
| FY2017 | Jun 30, 2017 | $764.28M | +1.7% |
| FY2016 | Jun 30, 2016 | $751.53M | +0.4% |
| FY2015 | Jun 30, 2015 | $748.59M | +8.2% |
| FY2014 | Jun 30, 2014 | $691.91M | +5.9% |
| FY2013 | Jun 30, 2013 | $653.15M | -0.1% |
| FY2012 | Jun 30, 2012 | $654.10M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $396.75M | +4.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $383.54M | +10.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $373.91M | +20.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $363.89M | +39.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $378.70M | +38.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $347.83M | +32.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $309.26M | +23.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $260.43M | +12.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $273.16M | +7.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $263.22M | +7.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $249.94M | +2.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $231.35M | -0.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $255.05M | -0.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $245.67M | +2.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $244.65M | +5.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $232.52M | +8.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $255.27M | +15.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $239.62M | +13.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $232.71M | +12.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $214.67M | +10.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $220.28M | +18.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $211.73M | +0.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $206.15M | -3.7% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $195.19M | +2.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $185.88M | -8.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $210.74M | +2.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $214.01M | -1.9% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $189.72M | -5.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $203.88M | -3.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $205.74M | -1.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $218.22M | +6.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $200.15M | +3.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $211.79M | +8.7% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $208.91M | +10.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $205.88M | +7.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $193.41M | +2.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $194.84M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $189.86M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $191.60M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $187.99M | – |
See a number that looks wrong?